Bajaj Finserv Mutual Fund logo

Bajaj Finserv Healthcare Fund-Reg(G)

Bajaj Finserv Mutual Fund

  • Equity
  • Sector Funds
  • Very High Risk

Performance Chart

Fund Overview

Assets Under Management (AUM)
₹332.52 Cr
Expense Ratio
2.09%
Riskometer
Very High
Category
Sector Funds
Asset Type
Equity
Benchmark
NIFTY 50 - TRI
SIP
Available
Switch
Available
Inception Date
18 May 2026
ISIN
INF0QA701987
Scheme Code
HCRG
Fund Scheme ID
39604

Thinking of investing in mutual funds?

Discover a simpler way to begin investing with Indipe.

Start Investing

Performance & Returns

Calculate SIP Returns

Returns by period

PeriodTrailing ReturnAbsolute ReturnAnnualised ReturnCAGR
1 Month2.82%2.82%33.15%55.65%
3 Months13.54%13.54%53.74%76.93%
6 Months26.77%26.77%53.11%57.88%
1 Year19.98%19.98%19.98%22.83%
Since Inception10.28%17.95%10.64%10.81%

Past performance is not indicative of future returns.

Portfolio

Asset Allocation

100.00%

  • Domestic Equities95.79%
  • Cash & Cash Equivalents and Net Assets2.66%
  • Domestic Mutual Funds Units1.55%

Top Sectors

  • Healthcare84.76%
  • Others2.68%
  • FMCG2.65%
  • Plastic Products2.23%
  • Chemicals2.14%
  • Finance1.53%
  • Retailing1.39%
  • Business Services1.12%

Holdings

Overview of fund allocations across sectors and securities

  • Healthcare

    Value

    ₹281.84 Cr

    Weightage

    84.76%

  • Others

    Value

    ₹8.91 Cr

    Weightage

    2.68%

  • FMCG

    Value

    ₹8.81 Cr

    Weightage

    2.65%

  • Plastic Products

    Value

    ₹7.42 Cr

    Weightage

    2.23%

  • Chemicals

    Value

    ₹7.12 Cr

    Weightage

    2.14%

  • Finance

    Value

    ₹5.09 Cr

    Weightage

    1.53%

  • Retailing

    Value

    ₹4.62 Cr

    Weightage

    1.39%

  • Business Services

    Value

    ₹3.72 Cr

    Weightage

    1.12%

  • Insurance

    Value

    ₹3.03 Cr

    Weightage

    0.91%

  • Capital Goods

    Value

    ₹1.96 Cr

    Weightage

    0.59%

About

Fund Manager(s)

Mr. Vinay Bafna, Mr. Siddharth Chaudhary

Launch Date

18 May 2026

Benchmark

NIFTY 50 - TRI

Objective

The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.

RISKOMETER

LOWLOW TOMODERATEMODERATEMODERATELYHIGHHIGH

The riskometer indicates the level of risk associated with the fund based on historical data and portfolio composition.

Exit Load, Stamp Duty and Tax Implication

Exit load
1% on or before 3M, Nil after 3M
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
--
Loading related funds